[go: up one dir, main page]

Kingma et al., 2010 - Google Patents

The effect of changes in perilymphatic K+ on the vestibular evoked potential in the guinea pig

Kingma et al., 2010

View HTML
Document ID
4877571303766962175
Author
Kingma C
Wit H
Publication year
Publication venue
European archives of oto-rhino-laryngology

External Links

Snippet

To investigate the effect on the functioning of the vestibular system of a rupture of Reissner's membrane, artificial endolymph was injected in scala media of ten guinea pigs and vestibular evoked potentials (VsEPs), evoked by vertical acceleration pulses, were …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0541—Cochlear electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Eshraghi et al. Molecular mechanisms involved in cochlear implantation trauma and the protection of hearing and auditory sensory cells by inhibition of c‐Jun‐N‐terminal kinase signaling
Perez et al. Vestibular and cochlear ototoxicity of topical antiseptics assessed by evoked potentials
Fujimoto et al. Autophagy is essential for hearing in mice
Fu et al. Ouabain-induced cochlear degeneration in rat
Abbas et al. Aminoglycoside ototoxicity and hair cell ablation in the adult gerbil: A simple model to study hair cell loss and regeneration
Liu et al. Spontaneous and partial repair of ribbon synapse in cochlear inner hair cells after ototoxic withdrawal
Nguyen et al. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015)
Asai et al. Transgenic Tmc2 expression preserves inner ear hair cells and vestibular function in mice lacking Tmc1
King et al. Gentamicin applied to the oval window suppresses vestibular function in guinea pigs
Plontke et al. A case series shows independent vestibular labyrinthine function after major surgical trauma to the human cochlea
Blanke et al. Histological study of the external, middle and inner ear of horses
Nouvian et al. Degeneration of sensory outer hair cells following pharmacological blockade of cochlear KCNQ channels in the adult guinea pig
Kingma et al. The effect of changes in perilymphatic K+ on the vestibular evoked potential in the guinea pig
Shimada et al. Macrophage depletion attenuates degeneration of spiral ganglion neurons in kanamycin-induced unilateral hearing loss model
Du et al. Degeneration of saccular hair cells caused by MITF gene mutation
Bako et al. The ototoxic effect of locally applied kanamycin and furosemide in guinea pigs
US7696197B2 (en) Use of a phenothiazine derivative for preventing and/or treating hearing loss
Kim et al. Semicircular canal drug delivery safely targets the inner ear perilymphatic space
Ozdogan et al. Investigation of the cochlear effects of intratympanic steroids administered following acoustic trauma
Suh et al. Compensation of vestibular function and plasticity of vestibular nucleus after unilateral cochleostomy
Wang et al. Changes in endocochlear potential during anoxia after intense noise exposure
Kada et al. A mouse model for degeneration of the spiral ligament
Pitaro et al. Ototoxicity of aluminum acetate/benzethonium chloride otic solution in the chinchilla animal model
Landegger et al. Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A
Takiguchi et al. Long-lasting changes in the cochlear K+ recycling structures after acute energy failure